Literature DB >> 27050331

Lung Ablation: Whats New?

Lillian Xiong1, Damian E Dupuy.   

Abstract

Lung cancer had an estimated incidence of 221,200 in 2015, making up 13% of all cancer diagnoses. Tumor ablation is an important treatment option for nonsurgical lung cancer and pulmonary metastatic patients. Radiofrequency ablation has been used for over a decade with newer modalities, microwave ablation, cryoablation, and irreversible electroporation presenting as additional and possibly improved treatment options for patients. This minimally invasive therapy is best for small primary lesions or favorably located metastatic tumors. These technologies can offer palliation and sometimes cure of thoracic malignancies. This article discusses the current available technologies and techniques available for tumor ablation.

Entities:  

Mesh:

Year:  2016        PMID: 27050331     DOI: 10.1097/RTI.0000000000000212

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  6 in total

Review 1.  Image-Guided Thermal Ablative Therapies in the Treatment of Sarcoma.

Authors:  Scott M Thompson; John J Schmitz; Grant D Schmit; Matthew R Callstrom; Anil Nicholas Kurup
Journal:  Curr Treat Options Oncol       Date:  2017-04

2.  Lung Ablation with Irreversible Electroporation Promotes Immune Cell Infiltration by Sparing Extracellular Matrix Proteins and Vasculature: Implications for Immunotherapy.

Authors:  Masashi Fujimori; Yasushi Kimura; Eisuke Ueshima; Damian E Dupuy; Prasad S Adusumilli; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Bioelectricity       Date:  2021-09-09

3.  Navigated Percutaneous Lung Ablation under High-Frequency Jet Ventilation of a Metastasis from a Wilms' Tumour: A Paediatric Case Report.

Authors:  Jacob Freedman; Piotr Harbut
Journal:  Case Rep Oncol       Date:  2016-07-29

4.  [Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors 
(2017 Edition)].

Authors:  Xin Ye; Weijun Fan; Hui Wang; Junjie Wang; Shanzhi Gu; Weijian Feng; Yiping Zhuang; Baodong Liu; Xiaoguang Li; Yuliang Li; Po Yang; Xia Yang; Wuwei Yang; Junhui Chen; Rong Zhang; Zhengyu Lin; Zhiqiang Meng; Kaiwen Hu; Chen Liu; Zhongmin Peng; Yue Han; Yong Jin; Guangyan Lei; Bo Zhai; Guanghui Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-07-20

5.  Computed Tomography-Guided Percutaneous Radiofrequency Ablation in Older Adults With Early-Stage Peripheral Lung Cancer: A Retrospective Cohort Study.

Authors:  Yanda Lu; Caiwei Lu; Danni Xu; Fen Huang; Zhihui He; Junhua Lei; Huamao Sun; Jiangzheng Zeng
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

6.  Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms.

Authors:  Roberto Iezzi; Andrea Contegiacomo; Alessandro Posa; Nico Attempati; Ernesto Punzi; Alessandro Tanzilli; Stefano Margaritora; Maria Teresa Congedo; Alessandra Cassano; Emilio Bria; Luca Tagliaferri; Vincenzo Valentini; Cesare Colosimo; Riccardo Manfredi
Journal:  Tomography       Date:  2021-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.